Mereo BioPharma (MREO) Operating Expenses (2023 - 2026)
Mereo BioPharma (MREO) posted quarterly Operating Expenses of $8.8 million for Q1 2026, down 21.75% year-over-year from $11.2 million in Q1 2025, and up 4.48% quarter-over-quarter from $8.4 million in Q4 2025.
Mereo BioPharma (MREO) Operating Expenses (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Operating Expenses for 4 consecutive years, with $8.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses fell 21.75% year-over-year to $8.8 million; the TTM figure through Mar 2026 stood at $38.3 million (down 21.22% YoY), while the FY2025 annual figure was $40.8 million, down 13.91% from the prior year.
- Operating Expenses grew to $8.8 million in Q1 2026 per MREO's latest filing, from $8.4 million in the prior quarter.
- Across five years, Operating Expenses topped out at $15.3 million in Q4 2024 and bottomed at $8.4 million in Q4 2025.
- Historically, Operating Expenses has averaged $10.5 million across 4 years, with a median of $10.1 million in 2024.
- Annual changes were most pronounced in 2024 — Operating Expenses soared 81.82% — and 2025, when it plunged 45.07%.
- Mereo BioPharma's Operating Expenses stood at $8.4 million in 2023, then jumped by 81.82% to $15.3 million in 2024, then tumbled by 45.07% to $8.4 million in 2025, then rose by 4.48% to $8.8 million in 2026.
- Business Quant data shows MREO's Operating Expenses at $8.8 million in Q1 2026, $8.4 million in Q4 2025, and $10.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Mereo BioPharma | 47.15 Mn | 47.15 Mn | - | 7.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.03 Mn |
| Mar 31, 2026 | 8.77 Mn |
| Dec 31, 2025 | 8.39 Mn |
| Sep 30, 2025 | 10.32 Mn |
| Jun 30, 2025 | 10.87 Mn |
| Mar 31, 2025 | 11.20 Mn |
| Dec 31, 2024 | 15.28 Mn |
| Sep 30, 2024 | 9.37 Mn |
| Jun 30, 2024 | 12.81 Mn |
| Mar 31, 2024 | 9.90 Mn |
| Dec 31, 2023 | 8.40 Mn |
| Sep 30, 2023 | 9.30 Mn |
| Mar 31, 2023 | 11.76 Mn |